Hydroxychloroquine (HCQ) reverses anti-PD-1 immune murine checkpoint blockade: TCF1 as a marker in humans for COVID-19 and HCQ therapy

Janna Krueger, Francois Santinon, Alexandra Kazanova, Mark Issa, Bruno Larrivee, Catalin Milhalcioiu, Christopher E. Rudd
doi: https://doi.org/10.1101/2020.09.29.20193110

Data Availability

All data referred to in the paper is available.

Back to top
Posted September 30, 2020.
Download PDF

Supplementary Material

Data/Code
Email
Hydroxychloroquine (HCQ) reverses anti-PD-1 immune murine checkpoint blockade: TCF1 as a marker in humans for COVID-19 and HCQ therapy
Janna Krueger, Francois Santinon, Alexandra Kazanova, Mark Issa, Bruno Larrivee, Catalin Milhalcioiu, Christopher E. Rudd
medRxiv 2020.09.29.20193110; doi: https://doi.org/10.1101/2020.09.29.20193110
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area